We’re committed to meaningfully integrating sustainability considerations into our business practices and culture.
Clinical research and development is complex. Finding the right partner shouldn’t be.
The work we do has a global impact, and we are committed to making it a positive one. Our corporate sustainability practice enables us to engage meaningfully with stakeholders, empower our team members, reduce our environmental impact, and evolve our business model through innovation.
Sustainable goals for a sustainable future.
We support the United Nations’ 17 Sustainable Development Goals, and our corporate goals align with three in particular:
- Health and Well-Being
- Gender Equality
- Industry Innovation and Infrastructure
We are also an IMPACT 2030 partner. IMPACT 2030 is a private sector, partnership-led initiative to achieve the UN’s goals. By working together, we believe we can make our world a healthier, more prosperous, and peaceful place.Read more about our partnership with IMPACT2030
Clinical Research and the COVID-19 Crisis Webinar
Master Protocols in Clinical Trials
Master protocols are a powerful but under-utilized option for complex clinical development programs. Our Greg Licholai, MD, explores:
The Challenges of Patient Recruitment in Oncology Trials - Part 3
A Phase I through Phase III oncology trial costs approximately $56.3 million and lasts for eight years. In 2012, it was reported that a typical…